|
1
|
Rzucidlo EM, Martin KA and Powell RJ:
Regulation of vascular smooth muscle cell differentiation. J Vasc
Surg. 45(Suppl A): A25–A32. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Dong N, Wang W, Tian J, Xie Z, Lv B, Dai
J, Jiang R, Huang D, Fang S, Tian J, et al: MicroRNA-182 prevents
vascular smooth muscle cell dedifferentiation via FGF9/PDGFRβ
signaling. Int J Mol Med. 39:791–798. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Shi N and Chen SY: Smooth muscle cell
differentiation: Model systems, regulatory mechanisms, and vascular
diseases. J Cell Physiol. 231:777–787. 2016. View Article : Google Scholar
|
|
4
|
Owens GK: Molecular control of vascular
smooth muscle cell differentiation and phenotypic plasticity.
Novart Found Symp. 283:174–191. 2007. View Article : Google Scholar
|
|
5
|
Chen Z and Xu X: Roles of nucleolin. Focus
on cancer and anti-cancer therapy. Saudi Med J. 37:1312–1318. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Jiang B, Zhang B, Liang P, Song J, Deng H,
Tu Z, Deng G and Xiao X: Nucleolin/C23 mediates the antiapoptotic
effect of heat shock protein 70 during oxidative stress. FEBS J.
277:642–652. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Fang L, Wang KK, Jiang L, Jiang BM, Wei X,
Song L, Deng GH and Xiao XZ: Role of cell-surface nucleolin in
lipopolysaccharide-stimulated expression and secretion of TNF-alpha
and IL-1beta. Zhong Nan Da Xue Xue Bao Yi Xue Ban. 33:999–1004.
2008.In Chinese. PubMed/NCBI
|
|
8
|
Huang F, Wu Y, Tan H, Guo T, Zhang K, Li D
and Tong Z: Phosphorylation of nucleolin is indispensable to its
involvement in the proliferation and migration of non-small cell
lung cancer cells. Oncol Rep. 41:590–598. 2019.
|
|
9
|
Wang Y, Mao M and Xu JC: Cell-surface
nucleolin is involved in lipopolysaccharide internalization and
signalling in alveolar macrophages. Cell Biol Int. 35:677–685.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Iliakis G, Krieg T, Guan J, Wang Y and
Leeper D: Evidence for an S-phase checkpoint regulating DNA
replication after heat shock: A review. Int J Hyperthermia.
20:240–249. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Huang Y, Shi H, Zhou H, Song X, Yuan S and
Luo Y: The angiogenic function of nucleolin is mediated by vascular
endothelial growth factor and nonmuscle myosin. Blood.
107:3564–3571. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Cheng Y, Zhao G, Zhang S, Nigim F, Zhou G,
Yu Z, Song Y, Chen Y and Li Y: AS1411-induced growth inhibition of
glioma cells by up-regulation of p53 and down-regulation of Bcl-2
and Akt1 via nucleolin. PLoS One. 11:e01670942016. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Fu Y, Chen Y, Luo X, Liang Y, Shi H, Gao
L, Zhan S, Zhou D and Luo Y: The heparin binding motif of
endostatin mediates its interaction with receptor nucleolin.
Biochemistry. 48:11655–11663. 2009. View Article : Google Scholar
|
|
14
|
Wang K, Deng G, Chen G, Liu M, Yi Y, Yang
T, McMillan DR and Xiao X: Heat shock protein 70 inhibits hydrogen
peroxide-induced nucleolar fragmentation via suppressing cleavage
and down-regulation of nucleolin. Cell Stress Chaperon. 17:121–130.
2012. View Article : Google Scholar
|
|
15
|
Khurts S, Masutomi K, Delgermaa L, Arai K,
Oishi N, Mizuno H, Hayashi N, Hahn WC and Murakami S: Nucleolin
interacts with telomerase. J Biol Chem. 279:51508–51515. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Jiang B, Liang P, Wang K, Lv C, Sun L,
Tong Z, Liu Y and Xiao X: Nucleolin involved in myocardial
ischaemic preconditioning via post-transcriptional control of
HSPA1A expression. Cardiovasc Res. 102:56–67. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Tulchin N, Chambon M, Juan G, Dikman S,
Strauchen J, Ornstein L, Billack B, Woods NT and Monteiro AN: BRCA1
protein and nucleolin colocalize in breast carcinoma tissue and
cancer cell lines. Am J Pathol. 176:1203–1214. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Mosafer J and Mokhtarzadeh A: Cell surface
nucleolin as a promising receptor for effective AS1411
aptamer-mediated targeted drug delivery into cancer cells. Curr
Drug Deliv. 15:1323–1329. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Kimes BW and Brandt BL: Characterization
of two putative smooth muscle cell lines from rat thoracic aorta.
Exp Cell Res. 98:349–366. 1976. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar
|
|
21
|
Tuan NQ, Lee DH, Oh J, Kim CS, Heo KS,
Myung CS and Na M: Inhibition of proliferation of vascular smooth
muscle cells by cucurbitanes from momordica charantia. J Nat Prod.
80:2018–2025. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Tang Y, Yu S, Liu Y, Zhang J, Han L and Xu
Z: MicroRNA-124 control human vascular smooth muscle cell
phenotypic switch via Sp1. Am J Physiol Heart Circ Physiol.
31:H641–H649. 2017. View Article : Google Scholar
|
|
23
|
Davis-Dusenbery BN, Wu C and Hata A:
Micromanaging vascular smooth muscle cell differentiation and
phenotypic modulation. Arterioscler Thromb Vasc Biol. 31:2370–2377.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Ma X, Jiang C, Li Y, Feng L, Liu J and
Wang J: Inhibition effect of tacrolimus and platelet-derived growth
factor-BB on restenosis after vascular intimal injury. Biomed
Pharmacother. 93:180–189. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Fang L, Chen MF, Xiao ZL, Liu Y, Yu GL,
Chen XB and Xie XM: Calcitonin gene-related peptide released from
endothelial progenitor cell inhibits the proliferation of rat
vascular smooth muscle cells induced by angiotensin II. Mol Cell
Biochem. 355:99–108. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Fang L, Chen MF, Xiao ZL, Yu GL, Chen XB
and Xie XM: The effect of endothelial progenitor cells on
angiotensin II-induced proliferation of cultured rat vascular
smooth muscle cells. J Cardiovasc Pharmacol. 58:617–625. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Zhang MJ, Zhou Y, Chen L, Wang YQ, Wang X,
Pi Y, Gao CY, Li JC and Zhang LL: An overview of potential
molecular mechanisms involved in VSMC phenotypic modulation.
Histochem Cell Biol. 145:119–130. 2016. View Article : Google Scholar
|
|
28
|
Andersen JS, Lyon CE, Fox AH, Leung AK,
Lam YW, Steen H, Mann M and Lamond AI: Directed proteomic analysis
of the human nucleolus. Curr Biol. 12:1–11. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Huang S: Building an efficient factory:
Where is pre-rRNA synthesized in the nucleolus. J Cell Biol.
157:739–741. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Li Y, Jiang B, Liang P, Tong Z, Liu M, Lv
Q, Liu Y, Liu X, Tang Y and Xiao X: Nucleolin protects macrophages
from oxLDL-induced foam cell formation through up-regulating ABCA1
expression. Biochem Biophys Res Commun. 486:364–371. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Bose S, Tholanikunnel TE, Reuben A,
Tholanikunnel BG and Spicer EK: Regulation of nucleolin expression
by miR-194, miR-206, and HuR. Mol Cell Biochem. 417:141–153. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Galande S: Chromatin (dis)organization and
cancer: BUR-binding proteins as biomarkers for cancer. Curr Cancer
Drug Targets. 2:157–190. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Reyes-Reyes EM and Akiyama SK:
Cell-surface nucleolin is a signal transducing P-selectin binding
protein for human colon carcinoma cells. Exp Cell Res.
314:2212–2223. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Chen T, Deng S and Lin R: The inhibitory
effect of Isoliquiritigenin on the proliferation of human arterial
smooth muscle cell. BM. Pharmacol Toxicol. 18:572017.
|
|
35
|
Yu XH, Zheng XL and Tang CK: Nuclear
Factor-κB activation as a pathological mechanism of lipid
metabolism and atherosclerosis. Adv Clin Chem. 70:1–30. 2015.
View Article : Google Scholar
|
|
36
|
Webster KA, Discher DJ and Bishopric NH:
Cardioprotection in an in vitro model of hypoxic preconditioning. J
Mol Cell Cardiol. 27:453–458. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Chen CY, Gherzi R, Andersen JS, Gaietta G,
Jürchott K, Royer HD, Mann M and Karin M: Nucleolin and YB-1 are
required for JNK-mediated interleukin-2 mRNA stabilization during
T-cell activation. Genes Dev. 14:1236–1248. 2000.PubMed/NCBI
|
|
38
|
Zhang Y, Bhatia D, Xia H, Castranova V,
Shi X and Chen F: Nucleolin links to arsenic-induced stabilization
of GADD45alpha mRNA. Nucleic Acids Res. 34:485–495. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Izawa Y, Yoshizumi M, Ishizawa K, Fujita
Y, Kondo S, Kagami S, Kawazoe K, Tsuchiya K, Tomita S and Tamaki T:
Big mitogen-activated protein kinase 1 (BMK1)/extracellular signal
regulated kinase 5 (ERK5) is involved in platelet-derived growth
factor(PDGF)-induced vascular smooth muscle cell migration.
Hypertens Res. 30:1107–1117. 2007. View Article : Google Scholar
|
|
40
|
Montezano AC, Callera GE, Yogi A, He Y,
Tostes RC, He G, Schiffrin EL and Touyz RM: Aldosterone and
Angiotensin II synergistically stimulate migration in vascular
smooth muscle cells through c-Src-regulated redox-sensitive RhoA
pathways. Arterioscler Thromb Vasc Biol. 28:1511–1518. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Wang S, Liu Y, Fan F, Yan J, Wang X and
Chen J: Inhibitory effects of emodin on the proliferation of
cultured rat vascular smooth muscle cell-induced by angiotensin II.
Phytother Res. 22:247–251. 2008. View Article : Google Scholar
|
|
42
|
Takahashi M, Hayashi K, Yoshida K, Ohkawa
Y, Komurasaki T, Kitabatake A, Ogawa A, Nishida W, Yano M, Monden M
and Sobue K: Epiregulin as a major autocrine/paracrine factor
released from ERK- and p38MAPK-activated vascular smooth muscle
cells. Circulation. 108:2524–2529. 2003. View Article : Google Scholar : PubMed/NCBI
|
